Skip to main content
. 2017 May 23;8(43):75617–75626. doi: 10.18632/oncotarget.18118

Figure 1. Relapse-free survival for patients with TNBC receiving standard chemotherapy (solid line) or standard chemotherapy plus carboplatin (dashed line).

Figure 1

Chisq = 0.1 on 1 degrees of freedom, p = 0.755.